Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir.
Pharmaceuticals (Basel). 2022 Nov 24;15(12):1456. doi: 10.3390/ph15121456.
Pharmaceuticals (Basel). 2022.
PMID: 36558907
Free PMC article.
Cite
Cite